Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease

BJU International

Volumn 104, Issue 3, 2009, Pages 304-309

  Helfand, Brian T ^a   Mongiu, Anne K ^a   Kan, Donghui ^a   Kim, Dae Yun ^a   Loeb, Stacy ^b   Roehl, Kimberly A ^c   Meeks, Joshua J ^a   Smith, Norm D ^a   Catalona, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BPH; Prostate cancer; PSA; Radical prostatectomy; T1a T1b

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; GLEASON SCORE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; SEMINAL VESICLE; TREATMENT OUTCOME;

AGED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 68049140913     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08421.x     Document Type: Article

References (19)

1. Mai KT, Isotalo PA, Green J, Perkins DG, Morash C, Collins JP. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening. Arch Pathol Laboratory Med 2000 124 : 1454 6
2. Tombal B, De Visccher L, Cosyns JP et al. Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers. BJU Int 1999 84 : 1015 20
3. Rogers E, Eastham JA, Ohori M et al. Impalpable prostate cancer: clinicopathological features. Br J Urol 1996 77 : 429 32
4. Jones JS, Follis HW, Johnson JR. Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis 2009 12 : 57 60
5. Zhang G, Wasserman NF, Ami Sidi A et al. Long-term followup results after expectant management of stage a 1 prostatic cancer. Editorial comments. J Urol 1991 146 : 99 103
6. Descazeaud A, Peyromaure M, Salin A et al. Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era. Eur Urol 2008 53 : 355 61
7. Argyropoulos A, Doumas K, Farmakis A, Aristas O, Kontogeorgos G, Lykourinas M. Characteristics of patients with stage T1b incidental prostate cancer. Scand J Urol Nephrol 2005 39 : 289 93
8. Robinson D, Aus G, Bak J et al. Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors. Scand J Urol Nephrol 2007 41 : 103 9
9. Masue N, Deguchi T, Nakano M, Ehara H, Uno H, Takahashi Y. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b. Int J Urol 2005 12 : 1045 9
10. Capitanio U, Scattoni V, Freschi M et al. Radical prostatectomy for incidental (stage t1a-t1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol 2008 54 : 118 25
11. Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy. J Urol 2007 178 : 1277 80
12. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004 172 : 2227 31
13. Chen WM, Yang CR, Ou YC et al. Clinical outcome of patients with stage T1a prostate cancer. J Chin Med Assoc 2003 66 : 236 40
14. Ozayar A, Zumrutbas AE, Yaman O. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH. Int Urol Nephrol 2008 40 : 933 9
15. Rosen RC. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia. Curr Opin Urol 2006 16 : 11 9
16. Rosen R, Altwein J, Boyle P et al. Lower urinary tract symptoms and male sexual dysfunction. Multinational Survey Aging Male (MSAM-7). Eur Urol 2003 44 : 637 49
17. Carbone DJ Jr, Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impotence Res 2003 15 : 299 306
18. Loeb S, Roehl KA, Helfand BT, Catalona WJ. Complications of open radical retropubic prostatectomy in potential candidates for active monitoring. Urology 2008 72 : 887 91
19. Bianco FJ Jr, Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005 173 : 2099 103